Richard E. Randall

University Of St. Andrews
Saint Andrews, SCT KY169ST, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

The V5-Epitope Tag for Cell Engineering and Its Use in Immunohistochemistry and Quantitative Flow Cytometry.

The V5-Epitope Tag for Cell Engineering and Its Use in Immunohistochemistry and Quantitative Flow Cytometry.

Journal: Biology

Published: April 30, 2025

The Cap-proximal secondary structures of the 5'UTRs of parainfluenza virus 5 mRNAs specify differential sensitivity to type I interferon and IFIT1.

The Cap-proximal secondary structures of the 5'UTRs of parainfluenza virus 5 mRNAs specify differential sensitivity to type I interferon and IFIT1.

Journal: The Journal of general virology

Published: March 27, 2025

Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody.

Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody.

Journal: The Journal of general virology

Published: January 09, 2025

ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans.

ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans.

Journal: European journal of immunology

Published: November 08, 2024

Liquid-liquid phase inclusion bodies in acute and persistent parainfluenaza virus type 5 infections.

Liquid-liquid phase inclusion bodies in acute and persistent parainfluenaza virus type 5 infections.

Journal: The Journal of general virology

Published: September 12, 2024

Persistent paramyxovirus infections: in co-infections the parainfluenza virus type 5 persistent phenotype is dominant over the lytic phenotype.

Persistent paramyxovirus infections: in co-infections the parainfluenza virus type 5 persistent phenotype is dominant over the lytic phenotype.

Journal: The Journal of general virology

Published: November 14, 2023

The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus Infection.

The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus Infection.

Journal: mBio

Published: April 25, 2023

Organic Light-Emitting Diode Based Fluorescence-Linked Immunosorbent Assay for SARS-CoV-2 Antibody Detection.

Organic Light-Emitting Diode Based Fluorescence-Linked Immunosorbent Assay for SARS-CoV-2 Antibody Detection.

Journal: Biosensors

Published: October 14, 2022

Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.

Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.

Journal: Frontiers in immunology

Published: March 02, 2022

Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity.

Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity.

Journal: Trends in genetics : TIG

Published: July 02, 2020

Innate Intracellular Antiviral Responses Restrict the Amplification of Defective Virus Genomes of Parainfluenza Virus 5.

Innate Intracellular Antiviral Responses Restrict the Amplification of Defective Virus Genomes of Parainfluenza Virus 5.

Journal: Journal of virology

Published: February 13, 2020

Direct Antiviral Activity of IFN-Stimulated Genes Is Responsible for Resistance to Paramyxoviruses in ISG15-Deficient Cells.

Direct Antiviral Activity of IFN-Stimulated Genes Is Responsible for Resistance to Paramyxoviruses in ISG15-Deficient Cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 12, 2019

Showing 1-12 of 47

Last Updated: 09/26/2026